Pharma Consulting

Pricing and Market Access Considerations for Cell and Gene

2020-03-04T22:43:35+00:00February 27th, 2020|Categories: Blog|Tags: , , , |

Pricing and Market Access Considerations for Cell and Gene In the past two years, four cell and gene therapies have entered the U.S. market at unprecedented prices. Most recently, Zolgensma launched at a price of $2.1 million for a one-time treatment. Payers view these new therapies as having moderate to high clinical value but have significant concerns around long term durability of effect. For example, will [...]

What is Compendia’s Impact on Product Decision Making?

2020-03-04T13:52:02+00:00February 26th, 2020|Categories: Blog|Tags: , , |

What is Compendia’s Impact on Product Decision Making? What is “The Compendia”? Most often, people describe the organizations that make up the Compendia as price books – and that’s understandable. After all, most of the submissions a manufacturer makes to Compendia involves price increases throughout the product launch year until they maintain price on a regular basis. And yes, pricing is absolutely a key part of what they do, however, [...]

An Overview of Cell and Gene Therapies

2020-03-04T13:53:10+00:00February 24th, 2020|Categories: Blog|Tags: , , , |

An Overview of Cell and Gene Therapies Since 2017, four new cell and gene therapies have become available in the U.S. with prices ranging from $373,000 to $2.1 million for a one-time administration. Gene Therapy Launch Timeline Gene Therapy Product Overview Product Indication Therapy Type Price Kymriah Childhood B-cell acute lymphoblastic leukemia (ALL) Diffuse large B-cell lymphoma (DLBCL) CAR-T [...]

Two Labs a Best Place to Work in Central Ohio

2020-02-25T16:40:19+00:00November 14th, 2019|Categories: Blog|Tags: , |

Two Labs is proud to be named as one of Columbus Business First’s 2019 Best Places to Work in Central Ohio. The Best Places to Work program, which is now in its 15th year, invites companies with at least 10 full time employees in Central Ohio to apply for the program by conducting an employee survey to assess satisfaction and happiness on the job. The winners of the [...]

Michael Rowe Joins Two Labs as DSCSA (Serialization) Compliance Services Manager

2020-02-25T18:03:36+00:00September 3rd, 2019|Categories: Blog|Tags: , |

At Two Labs, we value partnership. We work hard to make sure our clients view us as an extended part of their team, and not just another vendor. As the pharma market continues to evolve, we are excited to expand our team so that we can provide even more value to our clients as they navigate the path of bringing their products to market.  Two Labs welcomes Micheal Rowe [...]

Two Labs Joins Global Celebration of Rare Disease Day

2020-02-26T13:50:45+00:00February 28th, 2019|Categories: Blog|Tags: , , |

Since 2008, Rare Disease Day has been on the last day of February – which every four years is a rare 29th of the month. The observance was created to drive awareness of the 6,000 existing rare diseases that affect 1 in every 20 of us. As a way of demonstrating our support, we joined in on Rare Disease Day’s face-painting event at our offices, along with donations [...]

Two Labs Acquires Pennside Partners Ltd.

2020-02-26T14:08:38+00:00October 23rd, 2018|Categories: Blog|Tags: , , |

We’re excited to share today that as of  October 18, 2018, Two Labs has acquired Pennside Partners Ltd., a leading international provider of market insights, benchmarking, and competitive intelligence services for the pharmaceutical, biotech, and medical device sectors. This acquisition enhances Two Labs’ suite of services with complementary competitive intelligence services and extends its capabilities into clinical product insights allowing us to better meet clients’ evolving needs. At our [...]

Two Labs Hires Anita Dopkosky as Vice President of Specialty Pharmacy

2020-02-26T15:01:24+00:00May 10th, 2018|Categories: Blog|Tags: , |

At Two Labs, we value partnership. Our clients view us as an extended part of their team, not a vendor. And as the pharma market continues to evolve, we are excited for the growth we can experience by incorporating additional insightful team members. During Asembia’s 2018 Specialty Pharmacy Summit earlier this month, Two Labs welcomed Anita Dopkosky, a pharmaceutical industry executive, as Vice President of Specialty Pharmacy. She is [...]

Two Labs Acquires MKO Global Partners

2020-02-26T15:08:32+00:00February 8th, 2018|Categories: Blog|Tags: , , |

At Two Labs, we’re committed to staying at the forefront of the evolving healthcare market -- and to support our growth goals, we believe it’s invaluable to add insightful team members who have their own valuable perspectives. Today, we are pleased to share that as of February 2, 2018, Two Labs has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, [...]

The Basics of Licensing: In & Out, Drug, & Facility

2020-02-26T15:17:42+00:00January 5th, 2018|Categories: Blog|Tags: , |

When you conduct a quick online search using the following phrases, a vast array of answers will cross your screen: "License a Drug or Facility" "Pharma Licensing" "How to start my own Pharma Company" The results of these searches tend to center around licensing: in-licensing, out-licensing, drug licensing, and facility licensing. How does all of this relate to launching a drug? Here are the basics: [...]

Go to Top